Garantie de satisfaction à 100% Disponible immédiatement après paiement En ligne et en PDF Tu n'es attaché à rien
logo-home
Recherché précédemment par vous
Recherché précédemment par vous
logo
Samenvatting van alle colleges + medicijnen overzicht - MG: Infectious Diseases and Oncology (WBFA048-05) €6,99
Ajouter au panier
Accédez rapidement à
Aperçu
  2.  
  3. Rijksuniversiteit Groningen (RuG)
  4.  
  5. MG: Infectious Diseases and Oncology (WBFA04805)

Resume

Samenvatting van alle colleges + medicijnen overzicht - MG: Infectious Diseases and Oncology (WBFA048-05)
 0 fois vendu
  • Cours
  • MG: Infectious Diseases and Oncology (WBFA04805)
  • Établissement
  • Rijksuniversiteit Groningen (RuG)

Samenvatting van alle colleges van het van MG: Infectious Diseases and Oncology (WBFA048-05) aan de Rijksuniversiteit. Alle medicijnen die je moet kennen zijn in de tekst in het rood gemarkeerd wat het leren makkelijker maakt! De laatste 4 pagina's van dit document bevat een medicijnenlijst per lec...

[Montrer plus]

Aperçu 4 sur 66  pages

Infos sur le Document

  • 14 septembre 2024
  • 66
  • 2023/2024
  • Resume

Sujets

  • infectious diseases
  • oncology

École, étude et sujet

  • Rijksuniversiteit Groningen (RuG)
  • Farmacie
  • MG: Infectious Diseases and Oncology (WBFA04805)
Tous les documents sur ce sujet (4)

Vendeur

avatar-seller
sarahwierda

Aperçu du contenu

MG: Infectious diseases and Oncology

Lecture 1: Introduction
M. Balogh

Chemotherapy / anti-microbial therapy
- Selective toxicity  needs to have as little effect on healthy cells/tissue as possible.
- Two types of effect:
 Bactericide (in cancer cytotoxic)  kill bacteria.
 Needed in endocarditis, meningitis, immunocompromised patients.
 Bacteriostatic (in cancer cytostatic)  inhibit growth of bacteria and immune
mechanisms eliminate the bacteria.

Specific targets for the microorganisms
- Unique pathway only found in the pathogen.
 Cell wall synthesis inhibition  e.g. beta-lactams
 Folic acid synthesis inhibition
 Ergosterol synthesis inhibition  e.g. azols
 Binding to membrane ergosterol  e.g. amphotericin
 HIV protease inhibition
 Neuraminidase inhibition  influenza
- Similar pathway with some differences.
 Dihydrofolate reductase inhibition  e.g. trimethoprim, pyrimethamine
 Topoisomerase inhibition  e.g. fluoroquinolones
 Protein synthesis inhibition  e.g. macrolides, tetracyclines
 DNA, RNA polymerase inhibition
- Same pathway but with different significance.
 Dihydrofolate reductase inhibition  e.g. methotrexate
 Anti-metabolite nucleotides  e.g. 5-fluorouracil
 DNA polymerase  e.g. cytarabine

Principles of antimicrobial therapy
Is antimicrobial therapy right for a given patient?
1. Is it indicated on the basis of clinical findings?
2. Have appropriate clinical specimens been obtained to establish a microbial diagnosis?
3. What are the likely etiologic agents for the patients illness?
4. What measures should be taken to protect individuals exposed to the index case (patient) to
prevent secondary cases, and what measures should be implemented to prevent further
exposure?
5. Is there clinical evidence (e.g. from well-executed clinical trials) that antimicrobial therapy
will confer clinical benefit for the patient  most important question.

Once a cause is identifies  following questions
1. Is there a narrower-spectrum agent available to substitute the initial empiric drug?
2. Is one agent or a combination of agents necessary?
3. What is the optimal dose, route of administration, and duration of therapy?
4. What specific tests should be undertaken to identify patient who will no response to
treatment?
5. What adjunctive measures can be undertaken to eradicate the infection?


Therapy might be
1

, - Targeted
- Empiric (based on experience)
- Prophylactic (to prevent something from happening)  pre/post operative, during surgeries,
immune-deficient patients, recurrent infections, some infections.

Empiric AB therapy
- Based on experience with a particular clinical entity.
- Sometimes difficult to identify a specific pathogen  clinical response to empiric therapy
may be an important clue.
- It is indicated when there is a significant risk of serious morbidity or mortality if therapy is
withheld or for public health reasons.

Importance of proper treatment regimens
1. Effectiveness of therapy

Time dependent Abs  efficacy relates to the time that the concentration of a drug remains above
the MIC (minimal inhibitory concentration).
Concentration dependent Abs  efficacy relates to the peak concentration/MIC ratio. (Cmax/MIC)
Both (fluoroquinolones)  AUC/MIC.

Post-antibiotic effect (PAE)  suppression of bacterial growth after short antimicrobial exposure to
microorganisms.
- E.g. carbapenems, aminoglycosides, tetracyclines, quinolones, rifampicin.
- PAE = T * c
 T = time required for viable count in test culture to increase 10-fold above the count
before drug removal.
 C = time required for the count in an untreated culture to increase 10-fold above
count after completion of same procedure as test culture.
- Possible mechanisms of PAE
 Slow recovery after reversible nonlethal damage to cell structures.
 Persistence of the drug at a binding site of within the periplasmic space.
 The need to synthesize new enzymes before growth can resume.
- In vivo PAEs are usually much longer than in vitro PAEs.
- Aminoglycosides and quinolones possess concentration-dependent PAEs  high doses once
daily.

PK considerations
- iv administrations are more costly, and more possible to complications.
- Various diseases and physiological states alter the PK of antimicrobial agents  need
therapeutic drug monitoring (TDM)
- Most antimicrobial agents are well distributed to most body tissues and fluids, except
cerebrospinal fluid (BBB).

Therapeutic drug monitoring (TDM)
- General approach  variability among individuals can be characterized with population PK
models.
 Describing the typical behaviour, absorption/volume of distribution/clearance,
estimate of the influence of patient characteristics, development of such models.
- TDM
 Integration of PK (generally from population PK model) and PD knowledge to
optimize and personalize drug therapy.
 Important to consider the characteristics of the chosen population and the patient.
2

,  Different parameters might be more important for different drugs.

Bayesian simulation  application of population PK models in combination with individual patient
data (Cplasma)  dose adjustment.
- Advantages  flexible sampling (limited sampling strategy (LSS)) becomes applicable (1
sample enough to make predictions), population PK models counts for deviations and a
number of covariates.

Combination of drugs
- Most infections should be treated with a single antimicrobial agent.
- Antimicrobial combinations are often overused.
- Reasons for combinations
 Provide broad-spectrum empiric therapy in serious ill patients.
 Polymicrobial infections  e.g. intra-abdominal abscesses.
 To decrease the emergence of resistant strains  tuberculosis.
 To decrease dose-related toxicity.
 Enhances inhibition of killing
- BUT  bacteriostatic agents can antagonize the action of bactericidal cell wall-active agents.
General rule: do not combine cid + static.

2. Tolerance development
The misuse of AB therapy leads to the development of tolerance.
Do not use AB therapy for viral illnesses such as the common cold or sore throat. Patient compliance
if very important

Resistance
- Natural resistance
- Obtained resistance
 Mutation, then selection
 Mechanisms
 Enzyme production.
 Change in the target’s binding spot e.g. beta-lactamase.
 Decreased accumulation (active efflux, decreased uptake).
 Correction of damage, decrease in apoptosis (more in case of cancer).
 Transfer  between humans, between bacteria, via plasmids.




3

, The nosocomial ESKAPE pathogens  extremely hard to treat or even impossible. Hard to ESKAPE.

“Superbugs”  cause big trouble




Bacterial pathogens
- Gram negative  two membranes with a small layer of
peptidoglycan in the middle.
- Gram positive  thick peptidoglycan layer on top of their
membrane.
 After gram staining they have a crystal violet stain.

Different shapes  cocci (circles), bacilli (ovals), others

Bacterial pathogens examples
- Gram positive cocci
 Staphylococcus aureus  skin and wound infections, osteomyelitis, endocarditis.
 Streptococcus pyogenes skin and wound infections, tonsillopharyngitis, scarlet
fever.
 Streptococcus pneumonia (Pneumococcus)  respiratory infections.
 Streptococcus viridans group  dental infections, caries (tooth decay), endocarditis.
 Enterococcus  urinary infections, endocarditis.
- Gram positive bacillus
 Corynebacterium diphtheriae  diphtheria (DTaP vaccine!).
 Bacillus anthracis  anthrax.
- Gram negative cocci
 Neisseria meningitidis (Meningococcus)  meningitis
 Neisseria gonorrhoeae (Gonococcus)  gonorrhea (urethritis)
 Moraxella catarrhalis  respiratory infections (opportunistic pulmonary invader)
- Gram negative (other forms)
 Haemophilus influenzae  respiratory infections
 Helicobacter pylori  gastric ulcer
 Coliform bacteria (present in the environment and in the feces of all warm-blooded
animals and humans)
 Escherichia coli, Klebsiella spp., Proteus spp.  urinary infections
 Salmonella ssp., Shigella ssp.  diarrhea
 Pseudomonas aeruginosa  urinary infections, respiratory infections, wound
infections

Anaerobe bacteria
- Gram positive bacillus  clostridium ssp.
- Gram negative bascillus
 Bacteroides fragilis (and other B. ssp.)  gastrointestinal, gynecological, dental

4

Les avantages d'acheter des résumés chez Stuvia:

Qualité garantie par les avis des clients

Qualité garantie par les avis des clients

Les clients de Stuvia ont évalués plus de 700 000 résumés. C'est comme ça que vous savez que vous achetez les meilleurs documents.

L’achat facile et rapide

L’achat facile et rapide

Vous pouvez payer rapidement avec iDeal, carte de crédit ou Stuvia-crédit pour les résumés. Il n'y a pas d'adhésion nécessaire.

Focus sur l’essentiel

Focus sur l’essentiel

Vos camarades écrivent eux-mêmes les notes d’étude, c’est pourquoi les documents sont toujours fiables et à jour. Cela garantit que vous arrivez rapidement au coeur du matériel.

Foire aux questions

Qu'est-ce que j'obtiens en achetant ce document ?

Vous obtenez un PDF, disponible immédiatement après votre achat. Le document acheté est accessible à tout moment, n'importe où et indéfiniment via votre profil.

Garantie de remboursement : comment ça marche ?

Notre garantie de satisfaction garantit que vous trouverez toujours un document d'étude qui vous convient. Vous remplissez un formulaire et notre équipe du service client s'occupe du reste.

Auprès de qui est-ce que j'achète ce résumé ?

Stuvia est une place de marché. Alors, vous n'achetez donc pas ce document chez nous, mais auprès du vendeur sarahwierda. Stuvia facilite les paiements au vendeur.

Est-ce que j'aurai un abonnement?

Non, vous n'achetez ce résumé que pour €6,99. Vous n'êtes lié à rien après votre achat.

Peut-on faire confiance à Stuvia ?

4.6 étoiles sur Google & Trustpilot (+1000 avis)

64302 résumés ont été vendus ces 30 derniers jours

Fondée en 2010, la référence pour acheter des résumés depuis déjà 15 ans

Commencez à vendre!

Récemment vu par vous

Examen ·

(0)

FISDAP AIRWAY EXAM VERSION C LATEST 2023-2024 ACTUAL EXAM 100 QUESTIONS AND CORRECT ANSWERS AGRADE

Examen ·

(0)

Q-01 FDNY COMPLETE ACTUAL EXAM / 200+ WELL STRUCTURED QUESTIONS AND CORRECT ANSWERS 2023/2024 LATEST VERSION

Examen ·

(0)

WGU C175 Final+1+2. Data Management – Foundations. Questions and answers, 100% Accurate, Graded A+ 2024 | 20 Pages

Examen ·

(0)

Basic and Applied Concepts of Blood Banking and Transfusion Practices 4th Edition Howard Test Bank

Examen ·

(0)

Test Bank For Brunner & Suddarth's Textbook of Medical-Surgical Nursing 15th Edition Hunkle All Chapters

Examen ·

(0)

NR 601 Final Exam – Question with Answers NR 601 Final Exam – Question with 100% Answers latest document 2023

Examen ·

(0)

Texas Real Estate Practice Exam (2024 / 2025) Questions with Verified Answers, 100% Guarantee Pass Score

Pack ·

(0)

BUSI 300 Test 1, 2, 3, 4, BUSI 300 Quiz 1, 2, 3, 4 (Multiple Versions), Question and Answers , Liberty University.

Examen ·

(0)

CWB Level 2 Mod 9 Introduction to Welding Metallurgy of Steel Questions and Answers Already Passed

€6,99
  • (0)
Ajouter au panier
Ajouté